𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mo1029 Improved Outcomes in Hospitalized Patients With Cirrhosis Taking Beta Blockers

✍ Scribed by Aday, Ariel; Mayo, Marlyn J.; Chason, Rebecca D.; Rockey, Don C.

Book ID
122024587
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
229 KB
Volume
146
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Beta-blockers have no effect on outcomes
Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections
✍ Arnaud Galbois; Vincent Das; Dominique Thabut; Eric Maury; Hafid Ait-Oufella; Ch πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 378 KB πŸ‘ 2 views

We read with great interest the article by Stepanova et al. 1 In this report from the United States with 10,582 eligible individuals (1.52% of whom were positive for hepatitis C virus [HCV] antibody [anti-HCV]), the rate of insurance coverage was significantly lower in patients with HCV infection (6

Beta-blockers in patients with cirrhosis
Beta-blockers in patients with cirrhosis and refractory ascites
✍ Albillos AgustΓ­n; Zamora Javier πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 296 KB πŸ‘ 2 views

We read with interest the reviews by Ghouri et al. 1 and Martinez et al. 2 Ghouri et al. analyzed the association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD) and concluded that although a diagnosis of NAFLD should prompt diabetes screening, it is insufficient for co